title: New ultrasensitive detection technologies and techniques for use in microdosing studies.
abstract: In a microdosing study, subpharmacologically active doses of drug are given to human volunteers at an early stage of development in order to obtain preliminary pharmacokinetic data. The very low doses of drug administered (≤100 µg) consequently lead to very low concentrations of drug appearing in the body and therefore highly sensitive analytical techniques are required. There are three such analytical technologies currently used in microdosing studies: PET, liquid chromatography (LC)-tandem mass spectrometry (MS/MS) and accelerator mass spectrometry (AMS). Both PET and AMS employ radioisotopic tracers. PET is an imaging technique and AMS is an extremely sensitive isotope ratio method, able to measure drug concentrations in the ag/ml range. LC-MS/MS does not require the presence of an isotopic tracer and its sensitivity is in the pg/ml range. This review examines each of these three analytical modalities in the context of performing microdosing studies.
authors.affiliation: Xceleron Inc., Germantown, MD, USA. graham.lappin@xceleron.com
authors.forename: Graham
authors.initials: G
authors.lastname: Lappin
authors.forename: Claudia C
authors.initials: CC
authors.lastname: Wagner
authors.forename: Oliver
authors.initials: O
authors.lastname: Langer
authors.forename: Nico
authors.initials: N
authors.lastname: van de Merbel
mesh_terms: D002853:Chromatography, Liquid; D017321:Clinical Trials, Phase I as Topic / Q000379:methods*; D006801:Humans; D013058:Mass Spectrometry; D004364:Pharmaceutical Preparations / Q000008:administration & dosage* / Q000097:blood* / Q000378:metabolism; D049268:Positron-Emission Tomography; D012680:Sensitivity and Specificity; D053719:Tandem Mass Spectrometry
chemical_list: D004364:Pharmaceutical Preparations